Based on these observations, SH2B3, SF3B1, U2AF1, TP53, IDH2, and EZH2 were included as adverse mutations in ET and ASXL1, SRSF2, and IDH2 as adverse mutations in PV. The gene discussed is IDH2; the disease is essential thrombocythemia.